Search Results - "Skogastierna, C"
-
1
A supraphysiological dose of testosterone induces nitric oxide production and oxidative stress
Published in European journal of preventive cardiology (01-08-2014)“…Background Accumulating evidence indicates that abuse of anabolic androgenic steroids may cause cardiovascular adverse side-effects, including endothelial…”
Get full text
Journal Article -
2
Functional ATP-binding cassette drug efflux transporters in isolated human and rat hepatocytes significantly affect assessment of drug disposition
Published in Drug metabolism and disposition (01-03-2014)“…Freshly isolated hepatocytes are considered the gold standard for in vitro studies of hepatic drug disposition. To ensure a reliable supply of cells,…”
Get full text
Journal Article -
3
Cytochrome p450 inhibitory properties of common efflux transporter inhibitors
Published in Drug metabolism and disposition (01-03-2014)“…Drug transporter inhibitors are important tools to elucidate the contribution of transporters to drug disposition both in vitro and in vivo. These inhibitors…”
Get full text
Journal Article -
4
Statins inhibit expression of Thioredoxin reductase 1 in rat and human liver and reduce tumour development
Published in Biochemical and biophysical research communications (20-01-2012)“…► Statins inhibits expression of Thioredoxin reductase 1 in rat and human liver tissue. ► Statin-mediated inhibition of Thioredoxin reductases may explain…”
Get full text
Journal Article -
5
Single dose testosterone increases total cholesterol levels and induces the expression of HMG CoA reductase
Published in Substance abuse treatment, prevention and policy (20-03-2012)“…Cholesterol is mainly synthesised in liver and the rate-limiting step is the reduction of 3-hydroxy-3methylglutaryl coenzyme A (HMG-CoA) to mevalonate, a…”
Get full text
Journal Article -
6
Rapid Single-Nucleotide Polymorphism Detection of Cytochrome P450 (CYP2C9) and Vitamin K Epoxide Reductase (VKORC1) Genes for the Warfarin Dose Adjustment by the SMart-Amplification Process Version 2
Published in Clinical chemistry (Baltimore, Md.) (01-04-2009)“…Polymorphisms of the CYP2C9 (cytochrome P450, family 2, subfamily C, polypeptide 9) gene (CYP2C9*2, CYP2C9*3) and the VKORC1 (vitamin K epoxide reductase…”
Get full text
Journal Article -
7
Regulation and expression of human CYP7B1 in prostate: Overexpression of CYP7B1 during progression of prostatic adenocarcinoma
Published in The Prostate (15-09-2007)“…BACKGROUND Cytochrome P450 (CYP) 7B1 is involved in many metabolic processes including androgen metabolism. Cytochrome P450 (CYP) 7B1 is expressed within the…”
Get full text
Journal Article -
8
Regulation and expression of human CYP7131 in prostate:: Overexpression of CYP7131 during progression of prostatic adenocarcinoma
Published in The Prostate (15-09-2007)Get full text
Journal Article -
9
Influence of Simvastatin on the Thromboxane and Prostacyclin Pathways, In Vitro and In Vivo
Published in Journal of cardiovascular pharmacology (01-01-2013)“…3-hydroxyl-3-methylglutaryl coenzyme A reductase inhibitors (statins) are believed to exert beneficial effects against cardiovascular disease beyond correction…”
Get full text
Journal Article -
10
Beneficial vasoactive endothelial effects of fluvastatin: focus on prostacyclin and nitric oxide
Published in Heart and vessels (01-11-2011)“…Statins are believed to exert beneficial effects against cardiovascular disease beyond correction of dyslipidemia. There are however still very sparse data on…”
Get full text
Journal Article -
11
Daunorubicin metabolism in leukemic cells isolated from patients with acute myeloid leukemia
Published in Drug metabolism letters (01-12-2010)“…Anthracyclines like daunorubicin (DNR) are important drugs in the treatment of acute myeloid leukaemia (AML). In vitro studies have shown that cellular…”
Get more information
Journal Article -
12
THE PLEIOTROPIC EFFECTS OF FLUVASTATIN IN HUMAN VASCULAR ENDOTHELIUM
Published in BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2009)Get full text
Conference Proceeding